Study to Evaluate Neuromodulation Subject Experience With Contemporary Spinal Cord Stimulation (SCS) Modalities for Chronic Pain

Exclusion Criteria

• •3. Able to differentiate between pain associated with the indication for SCS implant and other types of pain, as determined by the Investigator or designee
• •4. Willing and able to use a personal smart phone for study surveys. NOTE: All subjects participating in the study must be willing to download the InsightPro™ clinical trial app and maintain current software updates on their own smart phone.
• •5. Willing and able to provide signed and dated informed consent in English
• •6. Willing and able to comply with all study procedures and visits
• •1. Any active implantable neuromodulation device or system (e.g., Peripheral Nerve Stimulation, Sacral Neuromodulation)
• •2. Currently participating, or plans to participate, in another investigational study or has a planned major medical procedure that may interfere with study procedures or confound study results, as determined by the Investigator or designee, unless documented pre-approval is provided by the sponsor
• •3. Major untreated or refractory psychiatric comorbidity or other progressive disease (e.g., neurodegenerative disease, heart failure, cancer) that may confound study results, as determined by the Investigator or designee
• •4. Serious drug-related behavioral issues (e.g., alcohol dependency, illegal substance abuse), as determined by the Investigator or designee
• •5. Pregnant or planning on becoming pregnant
• •6. Involved in an injury claim under current litigation, beneficiary of an injury claim, or receiving worker's compensation
• •7. Patients with buried lead trials/implants will be excluded from this study